D
Evome Medical Technologies Inc. LNDZF
$0.0112 -$0.0488-81.33%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
D
Sell 6/11/2024Upgraded
Evome Medical Technologies Inc. (LNDZF) was upgraded to D- from E+ on 6/11/2024 due to an increase in the volatility index and valuation index.
E
Sell 4/19/2024Downgrade
Evome Medical Technologies Inc. (LNDZF) was downgraded to E+ from D- on 4/19/2024 due to a noticeable decline in the growth index, solvency index and valuation index. Earnings per share declined from $0.0224 to -$0.1464, debt to equity increased from 1.01 to 4.43, and total revenue declined 25.01% from $14.17M to $10.63M.
D
Sell 4/12/2024Upgraded
Evome Medical Technologies Inc. (LNDZF) was upgraded to D- from E+ on 4/12/2024 due to an increase in the total return index and volatility index.
E
Sell 2/8/2024Downgrade
Evome Medical Technologies Inc. (LNDZF) was downgraded to E+ from D- on 2/8/2024 due to a noticeable decline in the total return index, volatility index and solvency index.
D
Sell 6/12/2023Upgraded
Salona Global Medical Device Corporation (LNDZF) was upgraded to D- from E+ on 6/12/2023 due to an increase in the volatility index.
E
Sell 5/24/2023Downgrade
Salona Global Medical Device Corporation (LNDZF) was downgraded to E+ from D- on 5/24/2023 due to a decline in the volatility index, solvency index and total return index. Debt to equity increased from 0.48 to 0.7, and the quick ratio declined from 0.38 to 0.3.
D
Sell 5/22/2023Upgraded
Salona Global Medical Device Corporation (LNDZF) was upgraded to D- from E+ on 5/22/2023 due to an increase in the volatility index.
E
Sell 5/5/2023Downgrade
Salona Global Medical Device Corporation (LNDZF) was downgraded to E+ from D- on 5/5/2023 due to a noticeable decline in the volatility index and total return index.
D
Sell 3/14/2023Downgrade
Salona Global Medical Device Corporation (LNDZF) was downgraded to D- from D on 3/14/2023 due to a decline in the volatility index.
D
Sell 2/23/2023Upgraded
Salona Global Medical Device Corporation (LNDZF) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index.
D
Sell 2/8/2023Downgrade
Salona Global Medical Device Corporation (LNDZF) was downgraded to D- from D on 2/8/2023 due to a noticeable decline in the solvency index, growth index and volatility index. The quick ratio declined from 0.59 to 0.38, debt to equity increased from 0.46 to 0.48, and total revenue declined 0.24% from $7.67M to $7.66M.
D
Sell 9/13/2022Downgrade
Salona Global Medical Device Corporation (LNDZF) was downgraded to D from D+ on 9/13/2022 due to a significant decline in the total return index, growth index and volatility index. Earnings per share declined from -$0.018 to -$0.0472.
D
Sell 6/3/2022Upgraded
Salona Global Medical Device Corporation (LNDZF) was upgraded to D+ from D on 6/3/2022 due to an increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.0267 to -$0.018.
D
Sell 5/31/2022Downgrade
Salona Global Medical Device Corporation (LNDZF) was downgraded to D from D+ on 5/31/2022 due to a decline in the volatility index.
D
Sell 5/16/2022Upgraded
Salona Global Medical Device Corporation (LNDZF) was upgraded to D+ from D- on 5/16/2022 due to an increase in the total return index and valuation index.
D
Sell 5/13/2022Downgrade
Evome Medical Technologies Inc. (LNDZF) was downgraded to D- from D+ on 05/13/2022.
D
Sell 5/10/2022Upgraded
Salona Global Medical Device Corporation (LNDZF) was upgraded to D+ from D- on 5/10/2022 due to an increase in the total return index and valuation index.
D
Sell 5/1/2022Downgrade
Salona Global Medical Device Corporation (LNDZF) was downgraded to D- from D+ on 5/1/2022 due to a decline in the valuation index.
D
Sell 4/21/2022Upgraded
Salona Global Medical Device Corporation (LNDZF) was upgraded to D+ from D- on 4/21/2022 due to an increase in the total return index.
D
Sell 4/20/2022Downgrade
Salona Global Medical Device Corporation (LNDZF) was downgraded to D- from D+ on 4/20/2022 due to a large decline in the total return index, solvency index and volatility index. The quick ratio declined from 0.73 to 0.39, and debt to equity increased from 0.54 to 0.62.
D
Sell 11/9/2021Upgraded
Salona Global Medical Device Corporation (LNDZF) was upgraded to D+ from D- on 11/9/2021 due to an increase in the valuation index.
D
Sell 11/8/2021Downgrade
Salona Global Medical Device Corporation (LNDZF) was downgraded to D- from D+ on 11/8/2021 due to a noticeable decline in the total return index, growth index and solvency index. Earnings per share declined from -$0.0161 to -$0.0195.
D
Sell 7/15/2021Upgraded
Salona Global Medical Device Corporation (LNDZF) was upgraded to D+ from D on 7/15/2021 due to a significant increase in the total return index, growth index and volatility index. Total revenue increased 723.12% from $57.1 to $470, and earnings per share increased from -$0.047 to -$0.0146.
D
Sell 5/21/2021Upgraded
Salona Global Medical Device Corporation (LNDZF) was upgraded to D from E+ on 5/21/2021 due to an increase in the valuation index.
E
Sell 5/20/2021Downgrade
Salona Global Medical Device Corporation (LNDZF) was downgraded to E+ from D- on 5/20/2021 due to a noticeable decline in the solvency index and volatility index. The quick ratio declined from 29.78 to 26.16.
D
Sell 11/2/2020Upgraded
Brattle Street Investment Corp. (LNDZF) was upgraded to D- from E+ on 11/2/2020 due to an increase in the total return index and volatility index.
E
Sell 6/26/2020Downgrade
Brattle Street Investment Corp. (LNDZF) was downgraded to E+ from D on 6/26/2020 due to a decline in the solvency index, volatility index and total return index.
D
Sell 5/6/2020Upgraded
Brattle Street Investment Corp. (LNDZF) was upgraded to D from D- on 5/6/2020 due to an increase in the volatility index and total return index.
D
Sell 4/20/2020Downgrade
Brattle Street Investment Corp. (LNDZF) was downgraded to D- from D on 4/20/2020 due to a noticeable decline in the growth index, efficiency index and solvency index. Operating cash flow declined 158.58% from -$47.8 to -$123.6, total revenue declined 72.16% from $529.5 to $147.4, and total capital declined 0.28% from $8.96M to $8.93M.
D
Sell 8/1/2019Upgraded
Inspira Financial Inc. (LNDZF) was upgraded to D from D- on 8/1/2019 due to a large increase in the solvency index, growth index and total return index. Total revenue increased 170.09% from -$670 to $469.6, and earnings per share increased from -$0.0188 to $0.0046.
D
Sell 7/16/2019Upgraded
Inspira Financial Inc. (LNDZF) was upgraded to D- from E+ on 7/16/2019 due to a significant increase in the solvency index, growth index and efficiency index.
E
Sell 7/1/2019Downgrade
Inspira Financial Inc. (LNDZF) was downgraded to E+ from D- on 7/1/2019 due to a significant decline in the solvency index and efficiency index.
D
Sell 6/7/2019Upgraded
Inspira Financial Inc. (LNDZF) was upgraded to D- from E+ on 6/7/2019 due to an increase in the total return index and volatility index.
E
Sell 5/23/2019Downgrade
Inspira Financial Inc. (LNDZF) was downgraded to E+ from D- on 5/23/2019 due to a decline in the total return index.
D
Sell 4/18/2019Upgraded
Inspira Financial Inc. (LNDZF) was upgraded to D- from E+ on 4/18/2019 due to an increase in the total return index, volatility index and solvency index.
E
Sell 8/6/2018Downgrade
Inspira Financial Inc. (LNDZF) was downgraded to E+ from D- on 8/6/2018 due to a decline in the dividend index.
D
Sell 7/20/2018Upgraded
Inspira Financial Inc. (LNDZF) was upgraded to D- from E+ on 7/20/2018 due to an increase in the dividend index.
E
Sell 7/5/2018Downgrade
Inspira Financial Inc. (LNDZF) was downgraded to E+ from D- on 7/5/2018 due to a large decline in the efficiency index, growth index and solvency index. Net income declined 5,693.46% from -$100.9 to -$5.85M, earnings per share declined from -$0.0024 to -$0.1278, and total revenue declined 713.01% from $743.1 to -$4.56M.
D
Sell 11/2/2017Downgrade
Inspira Financial Inc. (LNDZF) was downgraded to D- from D on 11/2/2017 due to a decline in the dividend index, growth index and total return index. Operating cash flow declined 99.32% from $2.73M to $18.6, and total revenue declined 12.3% from $826 to $724.4.
D
Sell 9/1/2017Upgraded
Inspira Financial Inc. (LNDZF) was upgraded to D from D- on 9/1/2017 due to an increase in the dividend index.
D
Sell 8/1/2017Downgrade
Inspira Financial Inc. (LNDZF) was downgraded to D- from D on 8/1/2017 due to a decline in the dividend index, efficiency index and solvency index. Debt to equity increased from 0.1 to 0.11, and total capital declined 4.97% from $16.41M to $15.59M.
D
Sell 7/17/2017Upgraded
Inspira Financial Inc. (LNDZF) was upgraded to D from D- on 7/17/2017 due to an increase in the dividend index, efficiency index and total return index.
D
Sell 6/30/2017Downgrade
Inspira Financial Inc. (LNDZF) was downgraded to D- from D on 6/30/2017 due to a decline in the efficiency index, growth index and solvency index. Net income declined 2,037.05% from -$272.6 to -$5.83M, earnings per share declined from -$0.0068 to -$0.1277, and total revenue declined 44.57% from $870.7 to $482.6.
D
Sell 11/4/2016Upgraded
Inspira Financial Inc. (LNDZF) was upgraded to D from D- on 11/4/2016 due to a major increase in the growth index and efficiency index. Net income increased 57.76% from -$324.6 to -$137.1, earnings per share increased from -$0.0087 to -$0.0077, and total revenue increased 10.39% from $580.1 to $640.4.
D
Sell 6/29/2016Upgraded
Inspira Financial Inc. (LNDZF) was upgraded to D- from E on 6/29/2016 due to an increase in the solvency index and valuation index. Debt to equity declined from 0.48 to 0.06.
E
Sell 3/16/2016Downgrade
Inspira Financial Inc. (LNDZF) was downgraded to E from E+ on 3/16/2016 due to a major decline in the volatility index and total return index.
E
Sell 3/1/2016Upgraded
Inspira Financial Inc. (LNDZF) was upgraded to E+ from E on 3/1/2016 due to an increase in the total return index, growth index and solvency index. Total revenue increased 76.82% from $609.1 to $1.08M, and debt to equity declined from 1.08 to 0.48.
E
Sell 12/10/2015None
Evome Medical Technologies Inc. (LNDZF) was downgraded to E from U on 12/10/2015.
Weiss Ratings